Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIMIZATION of the Dose of tacroliMUS by Bayesian Prediction in Renal Transplant Patients Including Pharmacogenetic Variables

NCT03465410 is registered in ClinicalTrials.gov with NURIA LLOBERAS BLANCH as lead sponsor.

NCT NCT03465410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIMIZATION of the Dose of tacroliMUS by Bayesian Prediction in Renal Transplant Patients Including Pharmacogenetic Variables
Lead sponsor
NURIA LLOBERAS BLANCH
Phase
Phase 4
Overall status
Completed
Start date
March 21, 2017
Completion date
September 21, 2020
Enrollment
96 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation